Published in Acta Physiol Scand on February 01, 1976
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 2.43
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
How does adenosine inhibit transmitter release? Trends Pharmacol Sci (1988) 2.20
A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem (1990) 2.11
Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol (1976) 2.09
The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) (2010) 2.06
Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol (1980) 1.81
Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci (1979) 1.80
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J (2001) 1.79
Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol (1999) 1.76
Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) (2007) 1.71
Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis (1997) 1.63
Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) (1999) 1.63
Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol (1982) 1.62
Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem (1991) 1.60
On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors. Acta Pharmacol Toxicol (Copenh) (1979) 1.58
Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J (1999) 1.57
Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS). Eur Heart J (2000) 1.53
Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls. Eur Heart J (1997) 1.47
Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls. Gender differences and relationships to catecholamines. Eur Heart J (1998) 1.46
Comparison of subcutaneous injection and high-dose inhalation of epinephrine--implications for self-treatment to prevent anaphylaxis. J Allergy Clin Immunol (1986) 1.45
Adenosine increases LPS-induced nuclear factor kappa B activation in smooth muscle cells via an intracellular mechanism and modulates it via actions on adenosine receptors. Acta Physiol (Oxf) (2013) 1.42
Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev (1992) 1.40
Inhibition of sodium-linked glucose reabsorption normalizes diabetes-induced glomerular hyperfiltration in conscious adenosine A₁-receptor deficient mice. Acta Physiol (Oxf) (2013) 1.40
Flow dependence of forearm noradrenaline overflow, as assessed during mental stress and sodium nitroprusside infusion. J Hypertens (1999) 1.39
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. J Physiol (1981) 1.39
Adenosine signaling and function in glial cells. Cell Death Differ (2009) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
[Randomization and ethics. Patient participation is a serious demand in medical research]. Lakartidningen (1992) 1.38
Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci (1992) 1.38
Adenosine receptors. Med Biol (1982) 1.37
Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? J Hypertens (1992) 1.36
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.35
Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett (1982) 1.34
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30
Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience (1998) 1.29
Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett (1985) 1.29
Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol (2000) 1.29
Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol (1988) 1.28
Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol (2000) 1.27
Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand (1991) 1.27
Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase. Biochem Pharmacol (1978) 1.27
The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia (1992) 1.26
Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci (1996) 1.25
Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim Biophys Acta (1976) 1.25
Pharmacology of adenosine A2A receptors. Trends Pharmacol Sci (1996) 1.23
Inhibitory effect of adenosine on adrenergic neuroeffector transmission in the rabbit heart. Acta Physiol Scand (1979) 1.23
ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. J Biol Chem (1992) 1.23
Fetal and maternal plasma catecholamine levels at elective cesarean section under general or epidural anesthesia versus vaginal delivery. Am J Obstet Gynecol (1982) 1.21
Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int (1993) 1.21
Adenosine analogues depress ventilation in rabbit neonates. Theophylline stimulation of respiration via adenosine receptors? Pediatr Res (1984) 1.21
Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J Pharmacol Exp Ther (1989) 1.20
Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res (1978) 1.19
Adenosine receptors mediating cyclic AMP production in the rat hippocampus. J Neurochem (1982) 1.19
Caffeine--an atypical drug of dependence. Drug Alcohol Depend (1998) 1.19
On the mechanism of action of theophylline and caffeine. Acta Med Scand (1985) 1.18
Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res (1994) 1.17
A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo. Acta Physiol Scand (1985) 1.16
Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand (1985) 1.15
Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience (1997) 1.14
Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res (1997) 1.13
Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) Eur Heart J (1996) 1.09
Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (1997) 1.09
Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience (2002) 1.09
Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease. Am Heart J (1984) 1.08
Adenosine receptors mediating inhibitory electrophysiological responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.08
Differentiated sympathetic activation during mental stress evoked by the Stroop test. Acta Physiol Scand Suppl (1984) 1.08
Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand (1982) 1.07
Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem Pharmacol (1999) 1.07
Catecholamine measurements by high-performance liquid chromatography. Am J Physiol (1984) 1.07
Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem Int (1995) 1.06
Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation (1999) 1.06
Sustained forearm vasodilation in humans during mental stress is not neurogenically mediated. Acta Physiol Scand (1996) 1.06
Theophylline actions on adenosine receptors. Eur J Respir Dis Suppl (1980) 1.05
Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.05
Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol (Oxf) (2007) 1.05
Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners. Eur J Clin Pharmacol (2001) 1.04
Adenosine, adenosine A 2A antagonists, and Parkinson's disease. Parkinsonism Relat Disord (2009) 1.04
Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun (1985) 1.03
Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage. Acta Physiol Scand (1985) 1.02
Characterization of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol (1983) 1.02
Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.02
The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci (1999) 1.02
Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells. Mol Pharmacol (1990) 1.02
Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol (2000) 1.02
Cyclic AMP independent inhibition by papaverine of histamine release induced by compound 48/80. Biochem Pharmacol (1976) 1.02
Cardiovascular effects of adenosine. Clin Physiol (1986) 1.01
Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes. Br J Clin Pharmacol (1989) 1.01
Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol (1987) 1.01
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J (1997) 1.01
Release of endogenous and radioactive purines from the rabbit retina. Brain Res (1986) 1.00
A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment. Brain Res (1997) 1.00
Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn Schmiedebergs Arch Pharmacol (1996) 1.00
Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience (1999) 1.00
Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci (1995) 0.99
Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension (1983) 0.99
Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J Pharmacol Exp Ther (1993) 0.99
Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.99